Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JO8Z
|
|||
| Former ID |
DNAP001648
|
|||
| Drug Name |
Fosfestrol
|
|||
| Synonyms |
fosfestrol; Diethylstilbestrol diphosphate; 522-40-7; Phosphestrol; Phosphoestrolum; Honvan; Stilbestrol diphosphate; Desdp; Diethylstilbestryl diphosphate; Diethylstilbesterol diphosphate; ST52-Asta; Fosfestrolum [INN-Latin]; UNII-A0E0NMA80F; CCRIS 2778; (E)-Hex-3-ene-3,4-diylbis(4,1-phenylene) bis(dihydrogen phosphate); C18H22O8P2; EINECS 208-328-8; A0E0NMA80F; CHEBI:4532; Diethylstilbestrol diphosphate [USP]; NCGC00181335-01; Stilphostrol (TN); alpha,alpha'-Diethyl-(E)-4,4'-stilbenediol bis(dihydrogen phosphate)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H22O8P2
|
|||
| Canonical SMILES |
CCC(=C(CC)C1=CC=C(C=C1)OP(=O)(O)O)C2=CC=C(C=C2)OP(=O)(O)O
|
|||
| InChI |
1S/C18H22O8P2/c1-3-17(13-5-9-15(10-6-13)25-27(19,20)21)18(4-2)14-7-11-16(12-8-14)26-28(22,23)24/h5-12H,3-4H2,1-2H3,(H2,19,20,21)(H2,22,23,24)/b18-17+
|
|||
| InChIKey |
NLORYLAYLIXTID-ISLYRVAYSA-N
|
|||
| CAS Number |
CAS 522-40-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10345, 7848009, 7979318, 10047183, 15329796, 36076580, 50047749, 50125929, 57352633, 76531220, 103770581, 111631913, 115354413, 126603657, 131549784, 134931955, 134977604, 137156414, 137545234, 143449629, 144206347, 162059604, 162172997, 163693541, 172858626, 179226216, 179316276, 184546059, 198986325, 223439533, 223535890, 225040070, 226400299, 241090562, 252350068
|
|||
| ChEBI ID |
CHEBI:4532
|
|||
| SuperDrug ATC ID |
G03CB02; G03CC05; L02AA04
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Impact of natural products on developing new anti-cancer agents. Chem Rev. 2009 Jul;109(7):3012-43. | |||
| REF 3 | Assay of the synthetic estrogen fosfestrol in pharmaceutical formulations using capillary electrophoresis. J Pharm Biomed Anal. 2005 Sep 15;39(3-4):559-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.